Genome-wide association study of germline variants and breast cancer-specific mortality
Authors
Escala-Garcia, MGuo, Q
Dork, T
Canisius, S
Keeman, R
Dennis, J
Beesley, J
Lecarpentier, J
Bolla, K
Wang, Q
Abraham, J
Andrulis, L
Anton-Culver, H
Arndt, V
Auer, L
Beckmann, W
Behrens, S
Benitez, J
Bermisheva, M
Bernstein, L
Blomqvist, C
Boeckx, B
Bojesen, E
Bonanni, B
Borresen-Dale, L
Brauch, H
Brenner, H
Brentnall, A
Brinton, L
Broberg, P
Brock, W
Brucker, Y
Burwinkel, B
Caldas, C
Caldes, T
Campa, D
Canzian, F
Carracedo, A
Carter, D
Castelao, E
Chang-Claude, J
Chanock, J
Chenevix-Trench, G
Cheng, D
Chin, F
Clarke, L
Cordina-Duverger, E
Couch, J
Cox, G
Cox, A
Cross, S
Czene, K
Daly, B
Devilee, P
Dunn, A
Dunning, M
Durcan, L
Dwek, M
Earl, M
Ekici, B
Eliassen, H
Ellberg, C
Engel, C
Eriksson, M
Evans, G
Figueroa, J
Flesch-Janys, D
Flyger, H
Gabrielson, M
Gago-Dominguez, M
Galle, E
Gapstur, M
Garcia-Closas, M
Garcia-Saenz, A
Gaudet, M
George, A
Georgoulias, V
Giles, G
Glendon, G
Goldgar, E
Gonzalez-Neira, A
Alnaes, G
Grip, M
Guenel, P
Haeberle, L
Hahnen, E
Haiman, A
Hakansson, N
Hall, P
Hamann, U
Hankinson, S
Harkness, F
Harrington, A
Hart, N
Hartikainen, JM
Hein, A
Hillemanns, P
Hiller, L
Holleczek, B
Hollestelle, A
Hooning, J
Hoover, N
Hopper, L
Howell, Anthony
Huang, G
Humphreys, K
Hunter, J
Janni, W
John, M
Jones, E
Jukkola-Vuorinen, A
Jung, A
Kaaks, R
Kabisch, M
Kaczmarek, K
Kerin, J
Khan, S
Khusnutdinova, E
Kiiski, I
Kitahara, M
Knight, A
Ko, D
Koppert, B
Kosma, M
Kraft, P
Kristensen, N
Kruger, U
Kuhl, T
Lambrechts, D
Le, L
Lee, E
Lejbkowicz, F
Li, L
Lindblom, A
Lindstrom, S
Linet, M
Lissowska, J
Lo, Y
Loibl, S
Lubinski, J
Lux, P
MacInnis, J
Maierthaler, M
Maishman, T
Makalic, E
Mannermaa, A
Manoochehri, M
Manoukian, S
Margolin, S
Martinez, E
Mavroudis, D
McLean, C
Meindl, A
Middha, P
Miller, N
Milne, L
Moreno, F
Mulligan, M
Mulot, C
Nassir, R
Neuhausen, L
Newman, T
Nielsen, F
Nordestgaard, G
Norman, A
Olsson, H
Orr, N
Pankratz, S
Park-Simon, TW
Perez, A
Perez-Barrios, C
Peterlongo, P
Petridis, C
Pinchev, M
Prajzendanc, K
Prentice, R
Presneau, N
Prokofieva, D
Pylkas, K
Rack, B
Radice, P
Ramachandran, D
Rennert, G
Rennert, S
Rhenius, V
Romero, A
Roylance, R
Saloustros, E
Sawyer, J
Schmidt, DF
Schmutzler, K
Schneeweiss, A
Schoemaker, J
Schumacher, F
Schwentner, L
Scott, J
Scott, C
Seynaeve, C
Shah, M
Simard, J
Smeets, A
Sohn, C
Southey, C
Swerdlow, J
Talhouk, A
Tamimi, M
Tapper, J
Teixeira, R
Tengstrom, M
Terry, B
Thone, K
Tollenaar, M
Tomlinson, I
Torres, D
Truong, T
Turman, C
Turnbull, C
Ulmer, U
Untch, M
Vachon, C
van Asperen, J
van den Ouweland, W
van Veen, M
Wendt, C
Whittemore, S
Willett, W
Winqvist, R
Wolk, A
Yang, R
Zhang, Y
Easton, F
Fasching, A
Nevanlinna, H
Eccles, M
Pharoah, P
Schmidt, K
Affiliation
Radiotherapy Department, Christie Hospital NHS Trust, Manchester, UKIssue Date
2019
Metadata
Show full item recordAbstract
BACKGROUND: We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry. METHODS: Meta-analyses included summary estimates based on Cox models of twelve datasets using ~10.4 million variants for 96,661 women with breast cancer and 7697 events (breast cancer-specific deaths). Oestrogen receptor (ER)-specific analyses were based on 64,171 ER-positive (4116) and 16,172 ER-negative (2125) patients. We evaluated the probability of a signal to be a true positive using the Bayesian false discovery probability (BFDP). RESULTS: We did not find any variant associated with breast cancer-specific mortality at P?<?5?×?10-8. For ER-positive disease, the most significantly associated variant was chr7:rs4717568 (BFDP?=?7%, P?=?1.28?×?10-7, hazard ratio [HR]?=?0.88, 95% confidence interval [CI]?=?0.84-0.92); the closest gene is AUTS2. For ER-negative disease, the most significant variant was chr7:rs67918676 (BFDP?=?11%, P?=?1.38?×?10-7, HR?=?1.27, 95% CI?=?1.16-1.39); located within a long intergenic non-coding RNA gene (AC004009.3), close to the HOXA gene cluster. CONCLUSIONS: We uncovered germline variants on chromosome 7 at BFDP?<?15% close to genes for which there is biological evidence related to breast cancer outcome. However, the paucity of variants associated with mortality at genome-wide significance underpins the challenge in providing genetic-based individualised prognostic information for breast cancer patients.Citation
Escala-Garcia M, Guo Q, Dork T, Canisius S, Keeman R, Dennis J, et al. Genome-wide association study of germline variants and breast cancer-specific mortality. Br J Cancer. 2019 Feb 21.Journal
British Journal of CancerDOI
10.1038/s41416-019-0393-xPubMed ID
30787463Additional Links
https://dx.doi.org/10.1038/s41416-019-0393-xType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41416-019-0393-x
Scopus Count
Collections
Related articles
- Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
- Authors: Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Cheng TD, Clarke CL, NBCS Collaborators, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Dörk T, Dossus L, Dunning AM, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Flyger H, Fritschi L, Gago-Dominguez M, García-Sáenz JA, Giles GG, Grip M, Guénel P, Gündert M, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hart SN, Hartikainen JM, Hartmann A, He W, Hooning MJ, Hoppe R, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators, kConFab Investigators, Jager A, Jakubowska A, Janni W, John EM, Jung AY, Kaaks R, Keupers M, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kurian AW, Lacey JV, Lambrechts D, Le Marchand L, Lindblom A, Linet M, Luben RN, Lubiński J, Lush M, Mannermaa A, Manoochehri M, Margolin S, Martens JWM, Martinez ME, Mavroudis D, Michailidou K, Milne RL, Mulligan AM, Muranen TA, Nevanlinna H, Newman WG, Nielsen SF, Nordestgaard BG, Olshan AF, Olsson H, Orr N, Park-Simon TW, Patel AV, Peissel B, Peterlongo P, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Rack B, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Ruebner M, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Scott C, Shah M, Smichkoska S, Southey MC, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teras LR, Terry MB, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Vachon CM, Wang Q, Hurson AN, Winqvist R, Wolk A, Ziogas A, Brauch H, García-Closas M, Pharoah PDP, Easton DF, Chenevix-Trench G, Schmidt MK
- Issue date: 2021 Aug 18
- Identification of novel genetic markers of breast cancer survival.
- Authors: Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, Shah M, Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Couch FJ, Olson JE, Vachon C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Broeks A, Hogervorst FB, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Cox A, Cross SS, Reed MW, Giles GG, Milne RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ, Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R, Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Brenner H, Dieffenbach AK, Arndt V, Holleczek B, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P, Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Bonanni B, Mariani P, Fasching PA, Beckmann MW, Hein A, Ekici AB, Chenevix-Trench G, Balleine R, kConFab Investigators, Phillips KA, Benitez J, Zamora MP, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hamann U, Kabisch M, Ulmer HU, Rüdiger T, Margolin S, Kristensen V, Nord S, Evans DG, Abraham JE, Earl HM, Hiller L, Dunn JA, Bowden S, Berg C, Campa D, Diver WR, Gapstur SM, Gaudet MM, Hankinson SE, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M, Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, García-Closas M, Hall P, Easton DF, Eccles DM, Rahman N, Nevanlinna H, Pharoah PD
- Issue date: 2015 May
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
- Authors: Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, Seibold P, Fasching PA, Andrulis IL, Kristensen VN, Couch FJ, Hamann U, Hooning MJ, Nevanlinna H, Eilber U, Bolla MK, Dennis J, Wang Q, Lindblom A, Mannermaa A, Lambrechts D, García-Closas M, Hall P, Chenevix-Trench G, Shah M, Luben R, Haeberle L, Ekici AB, Beckmann MW, Knight JA, Glendon G, Tchatchou S, Alnæs GI, Borresen-Dale AL, Nord S, Olson JE, Hallberg E, Vachon C, Torres D, Ulmer HU, Rüdiger T, Jager A, van Deurzen CH, Tilanus-Linthorst MM, Muranen TA, Aittomäki K, Blomqvist C, Margolin S, Kosma VM, Hartikainen JM, Kataja V, Hatse S, Wildiers H, Smeets A, Figueroa J, Chanock SJ, Lissowska J, Li J, Humphreys K, Phillips KA, kConFab Investigators, Linn S, Cornelissen S, van den Broek SA, Kang D, Choi JY, Park SK, Yoo KY, Hsiung CN, Wu PE, Hou MF, Shen CY, Teo SH, Taib NA, Yip CH, Ho GF, Matsuo K, Ito H, Iwata H, Tajima K, Dunning AM, Benitez J, Czene K, Sucheston LE, Maishman T, Tapper WJ, Eccles D, Easton DF, Schmidt MK, Chang-Claude J
- Issue date: 2015 Feb 10
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
- Authors: Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Arias JI, Menéndez P, Benítez J, Chang-Claude J, Hein R, Wang-Gohrke S, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Margolin S, Mannermaa A, Kosma VM, Kataja V, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Chen X, Chenevix-Trench G, Couch FJ, Olson JE, Fredericksen ZS, Wang X, Giles GG, Severi G, Baglietto L, Southey MC, Devilee P, Tollenaar RA, Seynaeve C, García-Closas M, Lissowska J, Sherman ME, Bolton KL, Hall P, Czene K, Cox A, Brock IW, Elliott GC, Reed MW, Greenberg D, Anton-Culver H, Ziogas A, Humphreys M, Easton DF, Caporaso NE, Pharoah PD
- Issue date: 2010 May 5
- Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.
- Authors: Ma H, Lu Y, Marchbanks PA, Folger SG, Strom BL, McDonald JA, Simon MS, Weiss LK, Malone KE, Burkman RT, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L
- Issue date: 2013